RxDoctor Payments Data

Lindsey Griswold, PA

Physician Assistant · West Des Moines, IANPI 1053996389

Payments from drug & device makers

$2,444in general payments, 2019–2025

Across 125 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$530
  • Otsuka America Pharmaceutical, Inc.$458
  • Sunovion Pharmaceuticals Inc.$318
  • Johnson & Johnson$256
  • AbbVie$245
  • Alkermes, Inc.$228
  • plus $409 from 5 others

What the payments were for

  • Food & beverage$2,444100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,444 in reported general payments places this provider in the 90th percentile of 1,140 physician assistant providers in Iowa.

See all physician assistant providers in Iowa

Medicare billing

Part B allowed, 2024
$7,993
Medicare patients
35
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate20$64,063
Risperidone ErRisperidone Microspheres11$25,128
Clozapine41$3,170
Aripiprazole65$2,959
Lurasidone Hcl13$1,832
Hydroxyzine Hcl36$1,033
Divalproex Sodium ErDivalproex Sodium18$963
Ramelteon13$962
Ziprasidone Hcl24$806
Quetiapine Fumarate31$723
Oxcarbazepine17$695
Benztropine Mesylate47$686
Prazosin Hcl11$613
Risperidone21$469
Bupropion XlBupropion Hcl28$456

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$256$64,06320 claims
Almatica Pharma LLCSertraline Hcl$51$25035 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,140 physician assistant providers in Iowa.

Other physician assistant in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →